This large population-based study highlights the significant burden of non-valvular atrial fibrillation, with a stable incidence rate but high early mortality, particularly in men and older patients.
No takes yet. Share an insight, caveat, or question.
Alerts clinicians to persistent early NVAF mortality; extends real-world incidence data while leaving open targeted prevention trials.
Renoux et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: